Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Operating Expenses: 2023-2024

Historic Operating Expenses for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $115.8 million.

  • CG Oncology's Operating Expenses rose 86.30% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.3 million, marking a year-over-year increase of 88.60%. This contributed to the annual value of $115.8 million for FY2024, which is 108.08% up from last year.
  • According to the latest figures from FY2024, CG Oncology's Operating Expenses is $115.8 million, which was up 108.08% from $55.7 million recorded in FY2023.
  • CG Oncology's Operating Expenses' 5-year high stood at $115.8 million during FY2024, with a 5-year trough of $55.7 million in FY2023.
  • Moreover, its 2-year median value for Operating Expenses was $85.7 million (2023), whereas its average is $85.7 million.
  • Data for CG Oncology's Operating Expenses shows a peak YoY soared of 108.08% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Operating Expenses (Yearly) stood at $55.7 million in 2023, then skyrocketed by 108.08% to $115.8 million in 2024.